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A systematic review of real-world diabetes
prevention programs: learnings from the
last 15 years
Zahra Aziz1*, Pilvikki Absetz2,3, John Oldroyd4, Nicolaas P. Pronk5 and Brian Oldenburg1
Abstract
Background: The evidence base for the prevention of type 2 diabetes mellitus (T2DM) has progressed rapidly from
efficacy trials to real-world translational studies and practical implementation trials over the last 15 years. However,
evidence for the effective implementation and translation of diabetes programs and their population impact needs
to be established in ways that are different from measuring program effectiveness. We report the findings of a
systematic review that focuses on identifying the critical success factors for implementing diabetes prevention
programs in real-world settings.
Methods: A systematic review of programs aimed at diabetes prevention was undertaken in order to evaluate their
outcomes using the penetration, implementation, participation, and effectiveness (PIPE) impact metric. A search for
relevant articles was carried out using PubMed (March 2015) and Web of Science, MEDLINE, CENTRAL, and EMBASE.
A quality coding system was developed and included studies were rated independently by three researchers.
Results: Thirty eight studies were included in the review. Almost all (92 %) provided details on participation; however,
only 18 % reported the coverage of their target population (penetration). Program intensity or implementation—as
measured by frequency of contacts during first year and intervention duration—was identified in all of the reported
studies, and 84 % of the studies also reported implementation fidelity; however, only 18 % of studies employed quality
assurance measures to assess the extent to which the program was delivered as planned. Sixteen and 26 % of studies
reported ‘highly’ or ‘moderately’ positive changes (effectiveness) respectively, based on weight loss. Six (16 %) studies
reported ‘high’ diabetes risk reduction but ‘low’ to ‘moderate’ weight loss only.
Conclusion: Our findings identify that program intensity plays a major role in weight loss outcomes. However,
programs that have high uptake—both in terms of good coverage of invitees and their willingness to accept the
invitation—can still have considerable impact in lowering diabetes risk in a population, even with a low intensity
intervention that only leads to low or moderate weight loss. From a public health perspective, this is an important
finding, especially for resource constrained settings. More use of the PIPE framework components will facilitate
increased uptake of T2DM prevention programs around the world.
Keywords: Implementation, Translational research, Diabetes prevention, Penetration, Implementation, Participation,
Effectiveness (PIPE) impact metric, Systematic review, Resource allocation
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Background
Type 2 diabetes mellitus (T2DM) has emerged as a
major public health challenge with an estimated 387 mil-
lion people living with T2DM globally [1]. Efforts to
prevent or delay the onset of diabetes are an urgent
public health priority with health, social, and economic
benefits. Several large randomized controlled trials
(RCTs) from the US, Finland, China, and India have
demonstrated that lifestyle interventions can be success-
ful in reducing the incidence of T2DM from 29–58 % in
high-risk populations [2–5], with generally good main-
tenance for up to 20 years [6, 7]. However, these trials
have mainly focused on efficacy and effectiveness out-
comes. It is now important that more emphasis is given
to the implementation and transferability of diabetes
prevention programs into real-world settings. ‘Imple-
mentation’ research focuses on understanding the pro-
cesses, results, and factors affecting implementation
under real-world conditions by answering questions
such as ‘why and how interventions work in real-world
settings’ [8]. ‘Transferability’ describes the process of ap-
plying the results of research in one situation to other
similar situations’ [9]. ‘Real-world’ contexts are settings
where health research findings are applied in practice.
The latter include primary healthcare settings, work or-
ganizations, churches, and schools. Major transferability
gaps still remain in translating diabetes prevention from
research into practice [10].
Several reviews of diabetes prevention trials have been
conducted to examine their effectiveness [11–23]. Some
recent reviews have examined how implementation in-
fluences effectiveness, most particularly in relation to
the US diabetes prevention program (US-DPP). One of
these reviews [24] summarized lifestyle interventions
based on the US-DPP curriculum and described how
different curricula (as a measure of implementation)
affected outcomes. They found that the less-intense
version of the US-DPP core curriculum may influence
long-term outcomes. Ali et al. [25] conducted a system-
atic review and meta-analysis of 28 translational studies
based on the US-DPP and concluded that the utilization
of non-medical personnel in delivering diabetes preven-
tion interventions can lower the overall costs without
compromising effectiveness. Johnson and colleagues
[26] synthesized evidence from translational studies
and assessed the impact of interventions delivered
outside large randomized trials. The review included
17 translational studies from a range of settings and
concluded that there is potential for less intensive
interventions to have an impact on future progres-
sion to diabetes in at-risk individuals. However, these
reviews included studies where subjects had either
already progressed to diabetes [25, 26] or had short
follow-up (e.g. less than 12 months [26]).
Another systematic review by Dunkley et al. [27] con-
cluded that pragmatic diabetes prevention programs are
effective and adherence to international guideline rec-
ommendations is significantly associated with a greater
weight loss; however, the authors mainly focussed on the
effectiveness of the selected translational studies in
relation to the main outcome without giving consider-
ation to the adaptability and scalability dimensions of
translation.
A more recent systematic review [28] assessing com-
bined diet and physical activity promotion programs of
between 3 months and 6 years duration concluded that
more intensive programs resulted in greater weight loss
and lowered the risk of T2DM more than less intensive
programs and this was also found to be cost-effective.
Based on the accumulated evidence from this and other
reviews, the US Community Preventive Services Task
Force (CPSTF) has recently recommended combined
diet and physical activity promotion programs to prevent
T2DM [28]. Importantly, however, the above review
examining the translation of diabetes prevention pro-
grams like US-DPP did not address issues specifically re-
lated to the long-term scalability and sustainability of
such programs.
Another comprehensive review to evaluate the
generalizability of diabetes prevention trials was con-
ducted by Whittemore [29] using Glasgow’s [30] reach, ef-
ficacy, adoption, implementation, maintenance (RE-AIM)
framework. This is a framework designed to summarize
how well research trials report on elements related to re-
search translation. Generalizability is an important elem-
ent of translational research, i.e. the degree to which
findings from a study or set of studies can be more
broadly generalized to populations and settings beyond
those in the original studies [31, 32]. This review included
16 studies that translated the US-DPP protocol into four
distinct settings: (a) hospital outpatient, (b) primary care,
(c) community, and (d) work and church. The author
found positive outcomes in terms of the reach, efficacy,
adoption, implementation, and maintenance of programs.
However, this review had a narrow focus and only in-
cluded those studies that were based on the US-DPP; no
other protocols were considered or included. Another
limitation was that several studies considered only short-
term effectiveness of up to 3 months, and some of the
included studies also recruited patients who already had
diabetes. Laws and colleagues [31] conducted a systematic
review examining the adequacy of reporting of external
validity components of lifestyle intervention trials
aimed at T2DM prevention. The authors assessed the
generalizability of the findings of 31 studies. Laws re-
ported that all studies lacked full reporting on exter-
nal validity elements. One of the limitations of this
review was the use of a dichotomous rating scale
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(‘reported’ or ‘not reported’) which did not take into
account external validity elements which were re-
ported as continuous measures [31].
In summary, a number of recent reviews have focused
on the real-world effectiveness of T2DM prevention, in
particular, programs derived from the US-DPP. However,
these reviews have not systematically examined the
adaptability and scalability dimensions of translation,
that is, what works, under what ‘real-world’ conditions
and in which contexts; yet this information is critically
important for policy makers and program implementers
who need to identify diabetes prevention programs with
significant population impact.
To address this knowledge gap, we have undertaken a
systematic review that focuses on identifying the critical
success factors for implementing diabetes prevention
programs in real-world settings. We consider the im-
portance of program and product design elements that
are important to real-world implementation including
the effect size, scope of services, scalability potential,
and long-term sustainability [33]. We use the penetra-
tion, implementation, participation, effectiveness (PIPE)
impact metric, a framework that is highly relevant to im-
plementation and a formal assessment of the net impact
of health improvement programs that is explicitly linked
to the program design elements noted above [33]. The
four key elements of the PIPE framework are as follows:
(1) penetration of the program into the population of
interest, (2) implementation of the proposed set of ser-
vices, (3) participation in the program, and (4) effective-
ness in generating expected outcomes. Each of the PIPE
Impact Metric elements may be expressed as a coeffi-
cient, and the product of these four coefficients is re-
ferred to as the PIPE impact metric. The PIPE Impact
Metric can be used to provide feedback to program
administrators on gaps in performance, and it also
enables the integration of program design features and
identifies where to focus on for performance improve-
ment changes. This paper aims to review the current
evidence about success factors for implementing dia-
betes prevention programs in real-world settings using
the PIPE Impact Metric.
Methods
Data sources and searches
A comprehensive search was carried out using PubMed,
Web of Science, MEDLINE, CENTRAL, and EMBASE
(February 2014). Search terms were ‘diabetes’ AND ‘pre-
vention’ AND (‘program’ OR ‘intervention’) AND (im-
plementation’ OR ‘translation’). The search was repeated
using PubMed to include relevant articles from February
2014 to March 2015. A detailed search strategy is pro-
vided in Additional file 1.
Study selection
We included all published studies in the last 15 years
(i.e. 2001–2015) that reported on the evaluation of a
lifestyle-focused program aimed at individuals at moder-
ate or high risk of diabetes (e.g. impaired glucose toler-
ance (IGT), elevated haemoglobin A1c (HbA1c), high
body mass index (BMI) or overweight). The inclusion
criteria were adults aged 18 years or older; English lan-
guage publications; and full text. The exclusion criteria
were studies that were published prior to 2001; that did
not report at least 1-year follow-up; included partici-
pants with known diabetes; included participants not at
elevated risk of developing diabetes; and reported on
multiple intervention components in a single study.
Studies were also excluded if they were exclusively ‘diet-
based’ or ‘exercise-based’ instead of referring to lifestyle
or behavioural interventions or if they used lifestyle and
pharmacological interventions.
Data extraction
An evaluation of T2DM prevention program impact was
conducted using the PIPE Impact Metric [33]. The PIPE
Impact Metric expresses four elements of program initi-
ation and long-term delivery needed to maximize the
population impact (i.e., penetration, implementation,
participation, and effectiveness) as a coefficient. The
product of all coefficients becomes the PIPE Impact
Metric. For example, a study may report having reached
250 out of 350 individuals at high risk for T2DM
workers at a company. In this example, penetration is re-
ported as (250/350) = 0.714 (71 %). Similar coefficients
are calculated for implementation, participation, and ef-
fectiveness. As numeric data was not available for some
of the elements in some of the included studies, an alter-
native coding system, also informed by PIPE, was devel-
oped for this paper.
Data synthesis and analysis
The coding system is summarized in Table 1. It included
two steps: (1) an initial scoring and (2) coding of the
scores into ‘high’, ‘medium’, ‘low’, or ‘not able to calculate
(NAC)’ where relevant data was not available. In the ini-
tial scoring, coefficients were calculated for penetration
and participation. For implementation, the initial scoring
was done on three aspects: frequency over the first
12 months; duration of the entire intervention including
follow-up contacts; and intervention fidelity. To over-
come heterogeneity in the kinds of contacts when scor-
ing frequency, a system was developed to standardize
the degree of contact based on number, length, and type
(Table 1). Similarly, for effectiveness, the initial scoring
was on three criteria: proportion of participants successful
in achieving the main outcome; weight loss (in kilo-
grammes); and diabetes risk reduction (absolute/relative).
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The coding of the scores (into high, medium, low, and
NAC) for each element was agreed-upon by the review
team, and ratings were independently derived by three re-
searchers (ZA, PA, JO). The ratings of all studies were
then reviewed by all authors, and when disagreement on
rating occurred, they were resolved with consensus among
all authors.
Results
A detailed PRISMA flow diagram is attached (Fig. 1).
The initial literature search (February 2014) returned
2992 publications and 61 additional articles were identi-
fied through hand searching of references from the bibli-
ographies of articles identified. Two thousand thirty-
nine articles were screened after removing duplicates.
An additional 5 articles were included after updating the
search until March 2015. A total of 180 articles were
assessed for eligibility. A total of 76 articles from 38
studies were included in the review. Table 2 describes
the characteristics of the included studies.
Studies that met the eligibility criteria for this review
were mainly based on either the US-DPP or Finnish-DPS.
Seventeen (45 %) studies were implemented in the USA, 4
in the UK, 4 in the Netherlands, 8 in other European
countries, 3 in Australia, and 2 in Japan. There were no
studies from low and middle income countries that met
our eligibility criteria. The sample size for the participants
enrolled in each of these studies ranged between 8 and
2553 participants. The studies were conducted in a range
of settings including primary health care, faith-based,
workplace, and other community-based settings.
Each study was assessed on the four components of
PIPE Impact Metric using a coding system described
in Table 1. Table 3 describes the ratings of all
Table 1 Development of coding system using PIPE Impact Metric elements
PIPE Element Description Coding of the scores
Penetration Numerator: the number of individuals reached (invited) ≤33 % = low; 34–66 % =moderate; ≥67 % = high; or NAC
(not able to calculate)
Denominator: the number of individuals in target population
Implementation Implementation was rated on 3 aspects. ≤33 % = low; 34–66 % =moderate; or ≥67 % = high
1. Frequency: the degree of contact (based on number, length,
and type) over the first 12 months of an intervention.
Different types of contacts were quantified based on the
session type in the following way:
• 1 group/individual session = 1 session
• 1 group/individual session (>3 h) = 2 sessions
• 1 online/telephone session = 0.5 session
• 1 text/email/fax contact = 0.25 session
Numerator: total number of sessions (over the first 12 months)
Denominator: 22 (the US-DPP 16 weekly + 6 monthly = 22 sessions)
2. Duration: the duration of the intervention ≤6 months = low; 6–12 months =moderate; and >12
months = high
3. Fidelity: the use of standard curriculum (for example: the
US-DPP) for the delivery of intervention and use of quality
assurance measures to monitor the implementation of the
intervention
No standard curriculum followed = low; a standard curriculum
was followed but no quality assurance measures were
reported =moderate; a standard curriculum was followed
and quality assurance measures were applied = high; or NAC
(not able to calculate)
Participation Numerator: the number of participants enrolled in the intervention ≤33 % = low; 34–66 % =moderate; ≥67 % = high; or NAC
(not able to calculate)
Denominator: the number of individuals reached (invited)
Effectiveness Effectiveness was rated on 3 criteria: ≤25 % = low; 26–40 % =moderate; >40 % = high; or NAC
(where information is not provided)
1. Success criterion/proportion of successful participants:
Numerator: participants who achieved the main outcome
(i.e. weight loss ≥5 %)
Denominator: total number of participants enrolled in the
intervention/total number of participants completed
12-month measurements
2. Average weight loss: the average weight loss (in kilogrammes) ≤2.3 kg = low; 2.4–4.6 kg =moderate; >4.6 kg = high; or
NAC (where information is not provided)
3. Risk reduction: diabetes risk reduction (absolute/relative) Risk reduction:
≤15 % = low; 16–30 % =moderate; >30 % = high; or NAC
(where information is not provided)
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included studies based on the elements of the PIPE
Impact Metric.
Program penetration
Our analysis shows that only nine (24 %) studies re-
ported their estimated target population, from which
only seven studies reported the proportion of the target
population that was reached with invitations to engage
in the program or intervention. Out of these seven stud-
ies, five had ‘high’, one had ‘moderate’, and one had ‘low’
penetration into their target populations (see Table 3
and Additional file 2: Table S4). Target populations in-
cluded patients, employees, and church attendees. Each
study used various strategies to recruit potential partici-
pants including mail invitations, posted flyers, advertis-
ing through media, contacting local physicians, local
churches, or using intranet or work meetings in the
workplace setting.
The five studies that were rated as having ‘high’ pene-
tration in our analysis applied heterogeneous strategies
to reach their target group. Two studies contacted a pre-
defined group of people at risk: one at worksite, where
all employees who had above average waist circumfer-
ence were invited for screening [34], and in the other
study [35] all eligible subjects with high risk for glucose
intolerance from a cohort representing general popula-
tion were contacted. Three studies contacted 100 % [36],
68 % [37], and 70 % [38] of the target population for se-
lective screening either by mail or by appointment. The
only study rated as having ‘moderate’ penetration, was a
church-based study [39]. The church roster included
407 members, whereas 37 % of adults (approximately
150) who attended Sunday gatherings were invited to
complete a diabetes risk assessment. The study rated as
having ‘low’ penetration in our analysis [40] included 18
participating centres that covered all primary care ser-
vices for 4.5 % of the population in Catalonia, out of
which less than 1 % of the population was invited for
screening.
Program implementation
In order to assess implementation, we evaluated the de-
gree of contact (based on number, length, and type) dur-
ing the first year of the intervention as frequency; the
duration of the entire intervention; and the fidelity of
the intervention (see Table 1). All studies in our analysis
reported on frequency and duration. Thirty-four percent
of all studies implemented ‘high’ frequency interven-
tions, and 39 % studies delivered intervention over the
period of 12 months or more. The number of contacts
varied from a single small group session to 32 group ses-
sions. About two thirds (66 %) of the programs based on
the US-DPP model adopted a ‘low-’ to ‘moderately in-
tense’ version (based on the degree of contact) as com-
pared to the original. The main adaptation was the
reduction from 16 to fewer sessions. In addition, groups
led by volunteers as opposed to health care professionals
and use of telephone as opposed to face-to-face delivery
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Fig. 1 PRISMA flow diagram
Aziz et al. Implementation Science  (2015) 10:172 Page 5 of 17
Table 2 Characteristics of the included studies
Year Author Study ID Country Setting Study population Sample
size
Study design Intervention
2003 Mensink et al.
[35]
SLIM Netherlands Unclear Adults at risk of T2DM 114 RCT 3 individual and 1 group session during 1 year +
participants were encouraged to participate in the
exercise program 3 times a year
2005 Kosaka et al.
[62]
Japanese DPP Japan Hospital-based Adults with IGT 458 RCT Detailed instructions on lifestyle were repeated every
3 to 4 months during hospital visits
2006 Oldroyd et al.
[63]
Newcastle lifestyle
intervention
UK Primary care Adults with IGT 78 RCT 12 individual 15- to 20-min review appointments over
24 months (6 in the first 6 months, 1 after 9 months
and 5 at 2 monthly intervals between 12 and 24
months)
2007 Absetz et al.
[41]
GOAL LIT Finland Primary care Adults at risk of T2DM 352 Before and after Six 2-hourly group counselling sessions over 8 months
2007 Bo et al. [36] Italian Trial Italy Primary care Adults with metabolic syndrome 335 RCT 1 individual and four 1-hourly group sessions
2007 Davis-Smith
et al. [39]
DPP (church-
based)
USA Community
(church)
Adults at risk of T2DM 10 Before and after 6-session lifestyle intervention delivered over a 7 week
period
2007 Laatikainen
et al. [64]
Greater Green
Triangle (GGT)
Australia Primary care Adults at risk of T2DM 311 Before and after 6 structured 90-min group sessions delivered during
an 8-month period
2008 Ackermann
et al. [65]
DEPLOY USA Community
(YMCA)
Adults at risk of T2DM 92 RCT Sixteen 1 to 1.5-hourly small group sessions over 16 to
20 weeks and monthly large-group meetings
2008 Boltri et al.
[66]
DPP (church-
based)
USA Community
(church)
Adults with pre-T2DM 8 Before and after 16 weekly group sessions conducted over 4 months
2008 Payne et al.
[67]
BDPPI Australia Outpatient setting Adults at risk of T2DM 122 Before and after 6-week group self-management education program,
12-week gym- or home-based resistance training, and
three 2-h group reinforcement sessions during
34-week maintenance program
2009 Kramer et al.
[68]
GLB (2007–2009) USA Community Adults with pre-T2DM 42 Before and after 12 weekly sessions (~60 min) and participants were
offered the opportunity to attend monthly support
meetings for 9 months after completion of the
intervention
2009 Kulzer et al.
[69]
PREDIAS Germany Outpatient setting Adults at risk of T2DM 182 RCT 12 lessons lasting ~90 min each
2009 Penn et al.
[70]
EDIPS—Newcastle UK Outpatient setting Adults with IGT 102 RCT A 30-min session immediately following randomisation
and 2 weeks later, then monthly for the first 3 months
and every 3 months thereafter up to 5 years
2010 Almeida et al.
[71]
Colorado weight
loss intervention
USA Integrated health
care organization
Adults with pre- T2DM 1520 Matched cohort A single 90-min small group session
2010 Makrilakis et al.
[72]
DE-PLAN Greece Greece Primary care
(workplace)
Adults at risk of T2DM 191 Before and after 6 sessions (1 h each) held by a registered dietician in
the groups of 6 to 10 persons
2010 Parikh et al.
[73]
Project HEED USA Community Adults at risk of T2DM 99 RCT A peer-led lifestyle intervention group, presented in a
workshop consisting of eight 1.5-h sessions over
10 weeks
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Table 2 Characteristics of the included studies (Continued)
2010 Vanderwood
et al. [45]
Montana CVD and
DPP
USA Health care
facilities
Adults at risk of T2DM and CVD 355 Before and after
(pilot study)
16 weekly group sessions and 6 monthly group
sessions
2010 Vermunt et al.
[74]
APHRODITE Netherlands Primary care Adults at risk of T2DM 925 RCT 11 consultations of 20-min over 2.5 years, five 1-h
group meetings and 1-h personal consultation with
the dietician
2011 Boltri et al.
[75]
DPP (church-
based)
USA Community
(church)
Adults with pre-T2DM 37 Before and after 6 or 16 weekly group sessions
2011 Gilis-
Januszewska
et al. [76]
DE-PLAN Poland Poland Primary care Adults at risk of T2DM 175 Prospective cohort 10 group sessions lasting for 4 months, 6 telephone
motivation sessions, and 2 motivation letters sent to
participant
2011 Katula et al.
[77]
HELP PD USA Community
(various venues)
Adults with pre-T2DM 301 RCT ~26 weekly group sessions for the first 6 months, 3
personalized consultations with a registered dietician,
18 monthly group sessions, and monthly phone contact
for the last 18 months
2011 Kumanyika
et al. [48]
Think health! USA Primary care Adults with high BMI and
weight
261 RCT Brief monthly contact with a lifestyle coach (LC) for
12
months and 10–15 min counselling sessions with
primary care providers every 4 months. Bi-monthly
sessions with LC for the second year
2011 Nilsen et al.
[42]
Nilsen et al. Norway Primary care Adults at risk of T2DM 213 RCT The individual and interdisciplinary group participated
in a group-based program, 1 day (5 h per day) each
week for 6 weeks
An individual 30-min consultation with a nurse or
ergonomist completed the intervention 1 month
after the last group meeting
2011 Penn et al.
[43]
NLNY UK Leisure and
community
settings
Adults at risk of T2DM 218 Before and after A 10-week program of twice-weekly 1.5-h sessions,
followed by ongoing support with regular mobile
phone text message and email reminders, ‘drop-in’
activity sessions continued up to 12 months
2011 Ruggiero et al.
[78]
HLP USA Community
(various venues)
Adults at risk of T2DM 69 Before and after 16 weekly core sessions and 6 monthly after-core
sessions
2011 Sakane et al.
[79]
Japanese Study Japan Primary care
(workplace)
Adults with IGT 304 RCT 4 group sessions of 2 to 3 h (for the first 6 months),
individual sessions twice a year for 3 years.
Between-visit contact by fax was also made
monthly during the initial 12 months
2012 Costa et al.
[40]
DE-PLAN-CAT Spain Primary care Adults at risk of T2DM 552 Prospective cohort A 6-h educational program (scheduled in 2 to 4
individual/small group sessions), and regular contact
by phone or text message for at least once every
6 to 8 weeks
2012 Janus et al.
[46]
pMDPS Australia Primary care Adults at risk of T2DM 92 RCT 6 structured 90-min group sessions. The first 5 sessions
were at 2 weeks intervals and the final session was 8
months after the first
2012 Kanaya et al.
[50]
LWBW USA Community Adults at risk of T2DM 238 RCT The intervention was primarily telephone-based
counselling (12 calls) with 2 in-person sessions
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Table 2 Characteristics of the included studies (Continued)
and 5 optional group workshops over 1 year
period
2012 Lakerveld et al.
[37]
Hoorn Prevention
Study
Netherlands Primary care Adults at risk of T2DM and/or
CVD
622 RCT Six individual 30-min counselling sessions,
followed by 3-monthly booster sessions by
phone for a period of 1 year.
2012 Ockene et al.
[80]
LLDPP USA Community Adults at risk of T2DM 312 RCT 3 individual and 13 group sessions over a
12 month period
2012 Piatt et al. [81] GLB (2005–2008) USA Community Adults with metabolic syndrome 105 Before and after 12 weekly sessions over 12 to 14 weeks
(lasted ~90 min) in the groups of 5 to
13 participants
2013 Jiang et al.
[82]
SDPI-DP USA Community Adults with pre-T2DM 2553 Before and after 16 group sessions in the first 16 to 24
weeks and monthly individual lifestyle
coaching sessions
2013 Ma J et al. [38] E-LITE USA Primary care Overweight/obese adults with
increased cardiometabolic risk
241 RCT 12 weekly group sessions (1.5 to 2 h each) in
the first 3 months. From month 4 to 15, contact
every 2 to 4 weeks depending on participant
needs and preferences. Individual, secure email/
phone contacts with personalized progress
feedback and lifestyle coaching throughout
the maintenance phase (month 4 to 15)
2014 Duijzer et al.
[49]
SLIMMER Netherlands Primary care Adults at risk of T2DM 31 One group pre-test
post-test
In addition to 6 individual consultations
(in total 4 h per participant),
on average, participants received
5.2 consultations by dieticians and 34.1 sports
lessons
2014 Sepah et al.
[47]
Prevent USA Online platform Adults with pre-T2DM 220 Quasi-experimental
research design
16 online weekly lessons. Participants were then
offered to continue with a post-core lifestyle change
maintenance intervention, with the entire intervention
(core plus post-core) totalling 12 months
2014 Zyriax et al.
[34]
DELIGHT Germany Primary care
(workplace)
Adults at risk of T2DM 241 Before and after 12 weekly sessions (for the first 6 months), 6 monthly
and 6 biweekly sessions (for the next 6 months).
For year 2 and 3 quarterly 1.5-h sessions
2015 Savas et al.
[44]
IGT care call UK Primary care Individuals with IGT 55 Observational
study
A telephone service providing a 6 month lifestyle
education program (20 min × 6), in addition to an
introduction call (10 min) and action planning
call (40 min)
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Table 3 Scoring for each PIPE element by study
Author Year Study Penetration Implementation Participation Effectiveness
Frequency Duration Fidelity Success rate Weight loss Risk reduction
(absolute/relative)
Mensink et al. 2003 [35] SLIM High Low High Low Low NAC Moderate High
Kosaka et al. 2005 [62] Japanese DPP NAC Low High Moderate NAC NAC Moderate High
Oldroyd et al. 2006 [63] Newcastle LI NAC Moderate High NAC Low NAC Low NR
Absetz et al. 2007 [41] GOAL LIT NAC Moderate Moderate Moderate High NAC Low NR
Bo et al. 2007 [36] Italian Trial High Low High High Low NAC Low High
Davis-Smith et al. 2007 [39] DPP (church-based) Moderate Low Low Moderate Low NAC High NR
Laatikainen et al. 2007 [64] GGT NAC Low Moderate High Low NAC Moderate NR
Ackermann et al. 2008 [65] DEPLOY NAC High High Moderate Low NAC High NR
Boltri et al. 2008 [66] DPP (church-based) NAC High Low Moderate Low NAC Low NR
Payne et al. 2008 [67] BDPPI NAC High High Moderate NAC Moderate Moderate NR
Kramer et al. 2009 [68] GLB (2007 – 2009) NAC High Moderate Moderate Low NAC High NR
Kulzer et al. 2009 [69] PREDIAS NAC Moderate Low Moderate NAC NAC Moderate NR
Penn et al. 2009 [70] EDIPS- Newcastle NAC Moderate High NAC Low NAC Low High
Almeida et al. 2010 [71] Colorado weight loss intervention NAC Low Low NAC Low Low Low NR
Makrilakis et al. 2010 [72] DE-PLAN Greece NAC Low Moderate Low Low NAC Low NR
Parikh et al. 2010 [73] Project HEED NAC Moderate Low Moderate Low Moderate Moderate NR
Vanderwood et al. 2010 [45] Montana CDDP NAC High Moderate Moderate High High High NR
Vermunt et al. 2010 [74] APHRODITE NAC Moderate High NAC Low NAC NAC NR
Boltri et al. 2011 [75] DPP (church-based) NAC Low (2 churches) Low Moderate Low NAC Low NR
High (3 churches)
Gilis-Januszewska et al. 2011 [76] DE-PLAN Poland NAC Moderate Moderate Low Low Low Low NR
Katula et al. 2011 [77] HELP PD NAC High High High Low NAC High NR
Kumanyika et al. 2011 [48] Think Health! NAC Moderate Moderate Moderate Moderate Low Low NR
Nilsen et al. 2011 [42] Nilsen et al. NAC High High NAC High Moderate NAC NR
Penn et al. 2011 [43] NLNY NAC High Moderate Low High Low Low NR
Ruggiero et al. 2011 [78] HLP NAC High Moderate Moderate Low Moderate Low NR
Sakane et al. 2011 [79] Japanese Study NAC Moderate High Moderate Low NAC Low High
Costa et al. 2012 [40] DE-PLAN-CAT Low Low High NAC Low NAC Low High
Janus et al. 2012 [46] pMDPS NAC Low Moderate High High NAC Moderate Moderate
Kanaya et al. 2012 [50] LWBW NAC Moderate Moderate Moderate Moderate NAC Low NR
Lakerveld et al. 2012 [37] Hoorn Prevention Study High Moderate Moderate High Low NAC NAC NR
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Table 3 Scoring for each PIPE element by study (Continued)
Ockene et al. 2012 [80] LLDPP NAC High Moderate Moderate Low NAC Low NR
Piatt et al. 2012 [81] GLB (2005–2008) NAC Moderate Moderate Moderate Low Moderate NAC NR
Jiang et al. 2013 [82] SDPI-DP NAC High Moderate Moderate Low NAC Moderate NR
Ma J et al. 2013 [38] E-LITE High High High High Low High High NR
Duijzer et al. 2014 [49] SLIMMER NAC Low Moderate Moderate Moderate NAC Moderate NR
Sepah et al. 2014 [47] Prevent NAC Moderate High Moderate High High NAC NR
Zyriax et al. 2014 [34] DELIGHT High High High Low Low NAC NAC NR
Savas et al. 2015 [44] IGT Care Call NAC Low Moderate High High NAC Moderate NR
Details on the scoring of all included studies based on the elements of the PIPE Impact Metric framework are provided in Additional file 2: Table S4–Table S7
NAC not able to calculate, NR not reported
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of individual sessions were also frequently observed ad-
aptations. Only a small proportion (16 %) of studies re-
ported ‘low’ duration, i.e. intervention delivered over the
period of 6 months or less.
Implementation fidelity was defined as intervention
being based on a standard curriculum for example the
US-DPP and whether any quality assurance measures
were applied to monitor the implementation of the
intervention. Twenty-seven (71 %) studies were based
on a standard curriculum, out of which only 7 studies
had quality assurance measures applied to monitor the
implementation. In some of these studies, while authors
reported on the efforts made to minimize the potential
lack of fidelity, none of these studies provided informa-
tion on the extent to which the various components
were delivered except one where the program compo-
nents were more frequently added (40 %) than omitted
(28 %) [41]. Refer to Table 3 and Additional file 2: Table
S5 for further details.
Program participation
The majority of the studies in our analysis (n = 35; 92 %)
reported participation. Twenty-five (71 %) of these 35
studies achieved ‘low’ participation rates. Half of these
studies achieved participation rates equivalent to or
lower than 10 %. Only 7 (18 %) studies had ‘high’ partici-
pation rates. For four of these studies [41–44], partici-
pants were recruited by referral from physicians, general
practitioners (GPs), or nurses from the participating
health facilities and invited to attend a screening clinic.
Two of the 7 studies [45, 46] used a combination of
strategies to recruit potential participants including con-
tacting local physicians and primary healthcare practices;
advertising through media; and recruiting through local
employers, work sites, churches, and service groups.
One study [47] recruited participants from online ad-
vertisement, seeking individuals with a self-reported
clinical diagnosis of prediabetes occurring within the
past year; however, recruitment was based on self-
selection by participants, which does not reflect a
truly random sample [47].
Three studies were scored as having ‘moderate’ partici-
pation, where 63 % [48], 57 % [49], and 44 % [50] of the
individuals were enrolled after assessing all ‘invited’ indi-
viduals, for study eligibility (see Table 3 and Additional
file 2: Table S6). In most of the remaining studies,
the ‘low’ participation was attributed to either the
non-eligibility of potential participants or the refusal
to participate.
For studies where information was available for both
penetration and participation, it was observed that ‘high’
penetration into the target population did not have posi-
tive effect on participation. All five studies rated as ‘high’
penetration in the analysis, reported ‘low’ participation.
Also, none of the seven studies that were rated as ‘high’
participation provided enough information on reaching
out to their target populations, and hence, penetration
could not be calculated. However, the information avail-
able suggests that the studies where high-risk partici-
pants were identified and referred through their GPs or
nurses resulted in ‘high’ participation rates.
Program effectiveness
Effectiveness was rated based on three criteria: propor-
tion of successful participants; average weight loss; and
diabetes risk reduction (absolute/relative) (Refer to
Table 1). None of the studies reported on all three cri-
teria. Seventeen (45 %) studies reported the use of
intent-to-treat analysis; however, for the purpose of our
analysis, effectiveness indicators were considered as pre-
sented in each of the studies.
One third (n = 12, 32 %) of the studies reported the
proportion of successful participants who achieved the
primary outcome (i.e. 5 % weight loss). The proportion
of successful participants ranged between 20 and 64 %.
Thirty-two (84 %) studies reported average weight loss
by participants at 12 months, with a range from 0.45 to
7.7 kg. Only six of these studies were rated ‘high’ where
average weight loss by participants was more than
4.6 kg. Sixteen (42 %) studies were rated ‘low’ on the
basis of average weight loss of ≤2.3 kg. Only seven
(18 %) studies reported the data on diabetes risk re-
duction (absolute/relative), where six studies were
rated ‘high’ and one was rated ‘moderate’. Scores
could not be calculated in three studies due to the
lack of numerical data.
Thirteen studies (34 %) were rated ‘high’ on at least
one of the three criteria. One study [45] that was rated
‘high’ on both success rate and weight loss, reported that
64 % of participants achieved 5 % weight loss goal with
the average 12-month weight loss of 7.7 kg. This study
was not only ‘highly’ effective but also had ‘high’ partici-
pation rates. The intervention included ‘high’ number of
sessions with ‘moderate’ duration and ‘moderate’ fidelity.
Another study [38] that had ‘high’ penetration into its
target population appeared to be ‘highly’ effective based
on the proportion of successful participants (50 %) and
average weight loss (6.3 kg at 15 months). This study
however, reported ‘low’ participation and delivered
‘high’ number of sessions and had ‘high’ duration of
intervention.
Five out of six studies that reported ‘high’ weight loss
delivered ‘high’ number of sessions.
Out of 10 studies that reported ‘moderate’ weight loss,
6 (60 %) implemented interventions with ‘low’ number
of sessions/contacts. Sixteen (42 %) studies had ‘low’ ef-
fectiveness based on average weight loss, out of these, 8
(50 %) studies delivered ‘moderate’ number of sessions,
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whereas 4 (25 %) delivered ‘high’ and 4 (25 %) delivered
‘low’ number of sessions. Six studies reported ‘high’ ef-
fectiveness in risk reduction despite ‘low’ (4 studies) or
‘moderate’ (2 studies) effectiveness in weight loss, and
these were also all studies with only ‘low’ (4 studies) or
‘moderate’ (2 studies) frequency, but with ‘high’ duration
(6 studies). See Table 3 and Additional file 2: Table S7
for more details.
Discussion
This is the first systematic review to evaluate the imple-
mentation of real-world diabetes prevention programs
using the PIPE Impact Metric framework that deploys
four highly relevant elements for monitoring program
impact in real-world settings. As such, this review com-
plements other recent reviews, e.g. Dunkley et al. 2014
[27], by providing a more detailed understanding of key
factors underlying successful translation and implemen-
tation of diabetes prevention programs in real-world
contexts. We have also defined the specific scope of
services for calculating the overall costs of services being
provided. From both an organizational and societal
perspectives, these issues are important to consider since
the relative costs and benefits of such services and
programs are important determinants of their uptake
and adoption. Our review of studies published over
the last 15 years aims to identify the components of
diabetes prevention programs with the highest popu-
lation impact.
Our review highlights several important findings. First,
confirming earlier reviews, our analysis demonstrates
that lifestyle-focused diabetes prevention programs that
have a ‘high’ degree of contact have more potential to
achieve effective outcomes, especially when measured by
weight loss. These programs have typically been based
on the US-DPP model and have used a very structured
protocol to maximize program fidelity. However, the
problem with this approach is that in these studies,
program participation tends to be quite low; and fur-
thermore, none of these studies reported diabetes risk
reduction.
Second, six of the studies showed different degrees of
effectiveness for different outcomes. For example, dia-
betes risk reduction could be ‘high’ even when effective-
ness in weight loss was ‘low’ or ‘moderate’. Surprisingly,
these were all studies of ‘low’ or ‘moderate’ frequency,
but ‘high’ duration. This could be very promising espe-
cially for settings where intervention resources are con-
strained but when large populations can be reached by
such programs.
Third, we found that ‘high’ penetration into the tar-
get population with invitations to engage prospective
participants in the program do not necessarily result
in ‘high’ participation. However, three studies with
‘high’ penetration resulted in either ‘high’ weight loss
or ‘high’ diabetes risk reduction. Hence, scalability of
the program to reach a large audience appears to be
an important ingredient for population-level impact.
In summary, while an intensive intervention plays an
important role in achieving successful weight loss out-
comes, highly scalable moderate- to low-frequency inter-
ventions appear to have major potential to achieve
diabetes risk reduction in populations.
From a program implementation perspective, it is im-
portant to clearly define and estimate the size of the tar-
get population. Without a reasonable estimate of the
size of the target population, there is a risk that the pro-
gram will not be scalable or sustainable [33]. We found
estimates of target populations to be reported by less
than one third of included studies. Hence, it is possible
that many of these programs were delivered to highly se-
lected populations which limit their generalizability.
We used the US-DPP intervention as a benchmark to
assess the intensity of dose-delivered (including fre-
quency, duration, and fidelity) in our included studies.
In order to deal with heterogeneity in the types of con-
tacts, we constructed a framework to standardize the
degree of contact based on number, length, and type.
We found that many programs adopted a ‘low-’ to ‘mod-
erately intense’ version, compared to the US-DPP inter-
vention. In practice, this also means that many of the
components were either omitted or modified from the
original US-DPP curriculum. As stated earlier, we also
note that ‘high’-frequency interventions with ‘high’ to
‘moderate’ duration and fidelity were associated with
greater weight loss. This is consistent with a systematic
review and meta-analysis by Dunkley et al. [27], where
reviewers coded intervention content based on the
recommendations for lifestyle interventions for the pre-
vention of diabetes provided by both the European
Guideline and Training Standard for Diabetes Preven-
tion (IMAGE) project [51] and National Institute for
Health and Care Excellence (NICE) [52] and found that
adherence to guidelines on the content and delivery was
significantly associated with a greater weight loss. Our
findings on the potential of ‘low’ to ‘moderate’ frequency
interventions with longer duration to achieve significant
risk reduction support earlier findings [25, 26]. A recent
CPSTF review [28] shows lower weight loss than the
US-DPP but still concluded strong evidence of effective-
ness. The recommendations from this review were fur-
ther supported by an effectiveness and economic review
[53, 54]. So, in general, it seems that studies beyond the
original US-DPP generate somewhat lower effect for
weight loss but still generate meaningful positive impact
on the reduction of incidence of T2DM. Lindstrom et al.
have also previously discussed the positive effects of de-
creased fat and increased fibre intake on diabetes risk
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reduction in the absence of weight loss [55]. We also
know that in many populations diabetes risk can be
high at lower levels of weight, with other factors be-
sides weight loss playing a critical role in risk reduc-
tion [56, 57].
Examining the implementation component further, in
calculating ‘frequency’, we have used contacts made in
the initial 12 months only because most of the studies
did not extend beyond 12 months. In those that did, the
initial 12 months can be considered as the ‘action’ phase,
bringing about the lifestyle changes, and beyond that is a
follow-up and maintenance phase, which some studies
support with less frequent contacts.
In translational research, a systematic evaluation of
program fidelity is important to assess the extent to
which program was implemented as designed. We based
our definition of fidelity on whether a standard curricu-
lum was used to guide the delivery of intervention and
whether quality assurance measures were placed to
monitor the implementation of the intervention. Not
many studies clearly reported whether the quality as-
surance measures were able to guarantee ‘high’ fidel-
ity, this clearly being one of the next important steps
in program development. This needs to be examined
in future studies.
All but three studies in our review reported participa-
tion, and only seven studies scored ‘high’ on participa-
tion rates. The high participation may be a reflection of
highly targeted penetration, but because of unavailability
of information, we could not calculate penetration coef-
ficients for any of these seven studies. However, the in-
formation available suggests that the studies where high-
risk participants were identified and referred through
their GPs or nurses resulted in ‘high’ participation rates,
underlying the important role of providers. The high
participation could also be a reflection of high motiv-
ation for change among at-risk individuals, a factor that
the providers can further enhance in face-to-face con-
tact, e.g. by applying strategies from motivational inter-
viewing [58]. In our review, of the seven studies that
scored ‘high’ for participation, five studies reported ‘high’
to ‘moderate’ effectiveness based on success rate and/or
weight loss.
The PIPE Impact Metric elements are interrelated in
that participation is always a proportion of penetration
and effectiveness can only be attributed to those who
participated. Effectiveness, in this context, is defined as
the number or proportion of participating cases who
reached a priori defined success criterion. In prevention
of T2DM, diabetes risk reduction is one such success
criterion. In many studies, however, weight loss was also
a main outcome—either in individual cases as a percent-
age of overall body weight or across a population as an
average percentage of weight loss. In our review, we
used either criterion—diabetes risk reduction or weight
loss—to assess effectiveness.
We found that weight loss was reported in several dif-
ferent ways. For example, the percentage weight lost
could be interpreted to mean weight loss to percentage
achieving a particular weight loss target or the average
percentage of weight that subject lost. One study [45] re-
ported both 5 and 7 % weight loss, whereas another [40]
reported the proportion of successful participants who
achieved at least 3 % weight loss. For consistency, in our
review, we only used 5 % weight loss when it was re-
ported in several different ways.
However, examination of studies with ‘low’ effective-
ness reveals that for some of the studies the reported
changes in weight loss were very small. Some of these
studies reported a significant reduction in weight follow-
ing the active intervention phase, but the weight was
partly or, in some studies, entirely regained by the end of
12 months. Lack of consistency in the way weight loss
outcomes are reported and analysed needs to be ad-
dressed in future translational research [29]. Cardona-
Morrell and colleagues [21] suggests the establishment
of a registry of translational projects using consistent,
measurable outcomes to add more certainty to effective-
ness analyses.
Our review includes diabetes prevention translational
programs published since 2001 and until 2015. The
studies included in this review have implemented ‘high’
(34 %), ‘moderate’ (37 %), and ‘low’ (29 %) frequency in-
terventions; however, we noticed that most of the ‘low-
frequency’ interventions were conducted in earlier years,
whereas, designing ‘moderate’ to ‘high’ intensity inter-
ventions occurred in more recent years. However, ‘par-
ticipation’ has been consistently low in a majority of the
studies over the last 15 years. One of the reasons for this
may be the fact that program planners focus on the con-
tent of the interventions instead of balancing the con-
tent with the experience of the participant—that is, on
the ‘participation’ dimension and the engagement factor
that connects the participant with the intervention.
Future translational research in this field needs to in-
vest in designing recruitment more carefully to ensure
high program reach; examining factors that optimize
engagement and retention in the structured lifestyle pro-
grams; and maximizing adherence to the long-term be-
haviour changes [59].
Limitations
Several studies did not provide relevant numeric data to
allow the calculation of PIPE coefficients. Hence we
were unable to compare the overall program impact of
the included studies. Additionally, any successfully trans-
lated diabetes program should ideally be accessible to those
most in need and should have some clear relationship with
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the health care delivery system, and we were not able to
evaluate these two elements in most of the studies included
in this review.
In our analysis of implementation, we only considered
standard sessions and have not included the extracurric-
ular or optional activities offered by some of the pro-
grams that may have impact on the future adoption of
these kinds of programs. This was mainly due to the het-
erogeneity in how the extracurricular activities were or-
ganized and also how they were reported. However, we
do acknowledge that these ‘spinoff ’ activities are likely to
be very important for sustainability and the wider diffu-
sion of programs, their maintenance, and sustainability.
Although there has been a lot of emphasis on the need
for translating T2DM programs in low and middle in-
come countries where the majority of people in the
world at high risk of diabetes and its progression live
[60], we did not find any studies from such countries
that met our eligibility criteria. The Kerala Diabetes Pre-
vention Program [61] in India is one of the first such im-
plementation trials to evaluate a peer-led, group-based
lifestyle intervention program (based on the Finnish
GOAL study) [41] among individuals at high risk of de-
veloping T2DM in rural India. The trial is currently be-
ing implemented and will provide important reference
to the translation of diabetes prevention programs in
India and similar countries.
Also, we did not find any studies that have previously
utilized the PIPE Impact Metric framework in diabetes
prevention. More research is needed to understand and
apply the few but essential elements of the PIPE model
to measure the overall public health impact of diabetes
prevention interventions.
Implications for practice
The original US-DPP [2] and Finnish-DPS [3] efficacy
trials demonstrated that lifestyle intervention is an ef-
fective way to reduce the risk of T2DM in high-risk
adults. However, achieving better translation of these
programs still remains challenging after 15 years of re-
search. Our findings suggest that program planners and
implementers should aim to design high-intensity pro-
gram with frequent contacts if the primary target is
weight loss. However, if the primary aim is diabetes risk
reduction, this can also be achieved with lower fre-
quency of contacts but with a program duration of at
least 12 months. With this program design, program
planners should expect only low or moderate weight
loss. To have a broader public health impact, programs
with lower frequency of contacts but with a program
duration of at least 12 months might be more feasible
but this requires program strategies that simultaneously
address both penetration and participation. Future trans-
lational research needs to identify effective recruitment
and program implementation strategies for targeting
both reach and program participation that also empha-
sizes long-term program adherence.
To improve the translation of diabetes prevention pro-
grams in real-world settings, we suggest a more rigorous
reporting of program elements and components to
evaluate these programs to assess the practical value
[27] of the diabetes prevention programs. In particular,
more detailed reporting on the four key PIPE Metric
components will provide important insights and has the
potential to facilitate increased uptake of T2DM prevention
programs worldwide. We also suggest a greater consistency
of reporting main outcomes and a standardization of
reporting criteria for translational diabetes prevention pro-
grams implemented in real-world settings.
Conclusions
Our findings based on program implementation over the
period of 15 years suggest that while a high-frequency
intervention plays an important role in achieving high
weight loss outcomes, programs with ‘low’-intense inter-
ventions have also shown high reductions in the inci-
dence of T2DM. This suggests that even when the
effectiveness of an intervention is moderate in terms of
weight loss, it can have a profound impact on the devel-
opment of a disease at the population level—provided
enough effort is put into guaranteeing high penetration
and participation as well. From a translation perspective,
not many studies provide the necessary information to
estimate the overall impact of such programs. Key ele-
ments of the PIPE Impact Metric are not routinely re-
ported in many published implementation trials of
diabetes prevention which therefore reduces their utility
for information resource allocation and ‘real-world’ im-
plementation. More rigorous evaluation methods are re-
quired to better understand the factors that influence
the likely success of such interventions in the future.
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